Purchases and Sales Made in Q2 2024 in Ovid Therapeutics Inc. (OVID)
This table provides information about the institutional ownership of Ovid Therapeutics Inc. (OVID) during Q2 2024. The information is specifically focused on institutions that hold shares of Ovid Therapeutics Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2024
Q2 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-28K- 68.95% |
$19.6K - $93.7K
|
12.6K
$13.1K
|
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-31K- 31.02% |
$21.7K - $104K
|
69K
$71.7K
|
|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-31K- 31.02% |
$21.7K - $104K
|
69K
$71.7K
|
|
|
Aug 13, 2024
Q2 2024
|
Ubs Group Ag
|
SELL
|
- |
-52.2K- 71.14% |
$36.6K - $174K
|
21.2K
$22K
|
|
|
Aug 09, 2024
Q2 2024
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-67.2K- 19.64% |
$47K - $224K
|
275K
$286K
|
|
|
Aug 14, 2024
Q2 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-67.9K- 46.55% |
$47.6K - $227K
|
78K
$81.1K
|
|
|
Aug 13, 2024
Q2 2024
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-107K- 48.03% |
$74.9K - $358K
|
116K
$120K
|
|
|
Aug 12, 2024
Q2 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-112K- 7.07% |
$78.1K - $373K
|
1.47M
$1.53M
|
|
|
Aug 07, 2024
Q2 2024
|
Tls Advisors LLC
Miami, FL |
SELL
|
- |
-194K- 14.73% |
$136K - $649K
|
1.13M
$1.17M
|
|
|
Aug 13, 2024
Q2 2024
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-203K- 4.84% |
$142K - $678K
|
3.99M
$4.15M
|